The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9
Canadian Journal of Gastroenterology and Hepatology · 13.06.2022 · 2022 · 1-7
DOI: 10.1155/2022/3953004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Canadian Journal of Gastroenterology and Hepatology, erschienen am 13.06.2022. Verfasst von Shun Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastrointestinal Surgery, Shanghai East Hospital, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: CA-19-9 Antigen, Stomach Neoplasms. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shanghai Pudong New Area Health Commission.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Traditionally, serum CEA and CA19-9 levels are good prognostic factors for gastric cancer. Many gastric cancer patients do not have elevated CEA or CA19-9 levels even at a very advanced stage. This study investigates the significance of the modified Glasgow prognostic score (mGPS) for the survival of gastric cancer patients with normal CEA and CA19-9.
Methods
We retrospectively examined 488 curatively resected gastric cancer patients with normal preoperative serum levels of CEA and CA19-9 to evaluate the prognostic ability of mGPS for overall survival. The prognostic significance was analyzed by univariate and multivariate analyses.
Results
Age, hemoglobin, white cell count, and neutrophils were each significantly correlated with the mGPS. Multivariate analyses showed that tumor location (HR, 0.803; 95% CI, 0.667–0.966; P = 0.020 ), TNM stage (HR, 2.714; 95% CI, 2.250–3.275; P < 0.001 ), and mGPS (HR, 1.042; 95% CI, 1.105–1.772; P = 0.023 ) were significantly associated with overall survival. Significant correlations were found between overall survival and mGPS. The Kaplan–Meier analysis demonstrated significant differences among patients with mGPS of 0, 1, and 2 P < 0.001 , with the mortality rate being higher for patients with a higher mGPS.
Conclusion
The mGPS can predict survival in gastric cancer patients with normal CEA and CA19-9.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Gastrointestinal Surgery, Shanghai East Hospital, Tongji University, Shanghai, China.
- Center of Digestive Endoscopy, Shanghai East Hospital, Tongji University, Shanghai, China.
ORCID-Profile: Shun Zhang, Xiao-Hua Jiang
Förderung
- Shanghai Pudong New Area Health Commission
Zitieren
APA
Zhang, S., Li, J. Z., Du, T., Li, H. Q., Hu, R. H., Ma, C. Y., Cui, X. M., Song, C., & Jiang, X. H. (2022). The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9. Canadian Journal of Gastroenterology and Hepatology, 2022, 1-7. https://doi.org/10.1155/2022/3953004
Vancouver
Zhang S, Li JZ, Du T, Li HQ, Hu RH, Ma CY, et al. The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9. Canadian Journal of Gastroenterology and Hepatology. 2022;2022:1-7. doi:10.1155/2022/3953004
BibTeX
@article{Zhang2022,
author = {Zhang, Shun and Li, Jing-Ze and Du, Tao and Li, Hai-Qiang and Hu, Ren-Hao and Ma, Chi-Ye and Cui, Xi-Mao and Song, Chun and Jiang, Xiao-Hua},
title = {The Modified Glasgow Prognostic Score Predicts Survival in Gastric Cancer Patients with Normal CEA and CA19-9},
journal = {Canadian Journal of Gastroenterology and Hepatology},
year = {2022},
volume = {2022},
pages = {1--7},
doi = {10.1155/2022/3953004}
}
EUVIMED